GENETIC SEQUENCING AND IMMUNOHISTOCHEMICAL STAINING IN METASTATIC NON-SMALL CELL LUNG CANCER
- Authors: Peled N.1, Palmer G.1, Hirsch R.1, Wines M.1, Illuis M.1, Varea-Garcia M.1, Sussan-Gutman L.1, Otto D.1, Stivens F.1, Ross D.1, Kronin M.1, Lipson D.1, Miller V.1
-
Affiliations:
- Issue: Vol 25, No 11 (2014)
- Pages: 64-65
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116209
- ID: 116209
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
N. Peled
Email: yuta@hmc-israel.org.il
G. Palmer
Email: yuta@hmc-israel.org.il
R. Hirsch
Email: yuta@hmc-israel.org.il
M. Wines
Email: yuta@hmc-israel.org.il
M. Illuis
Email: yuta@hmc-israel.org.il
M. Varea-Garcia
Email: yuta@hmc-israel.org.il
L. Sussan-Gutman
Email: yuta@hmc-israel.org.il
D. Otto
Email: yuta@hmc-israel.org.il
F. Stivens
Email: yuta@hmc-israel.org.il
D. Ross
Email: yuta@hmc-israel.org.il
M. Kronin
Email: yuta@hmc-israel.org.il
D. Lipson
Email: yuta@hmc-israel.org.il
V. Miller
Email: yuta@hmc-israel.org.il
References
- Kwak E., Bang Y., Camidge D. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer // N. Engl. J. Med. - 2010; 363: 1693-703.
- Shaw A., Yeap B., Mino-Kenudson M. et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK // J. Clin. Oncol. - 2009; 27: 4247-53.
- Rikova K., Guo A., Zeng Q. et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer // Cell. - 2007; 131: 1190-203.
- Soda M., Choi Y., Enomoto M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer // Nature. - 2007; 448: 561-6.
- Lipson D., Capelletti M., Yelensky R. et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies // Nat. Med. - 2012; 18: 382-6.
- Wong D., Leung E., So K. et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS // Cancer. - 2009; 115: 1723-33.
- Inamura K., Takeuchi K., Togashi Y. et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset // Mod. Pathol. - 2009; 22: 508-15.
Supplementary files
![](/img/style/loading.gif)